ferroptosis inhibitors (Collaborative Medicinal Development)

N/A

Report date: 2025/03/20 16:00:39
NME

Base Information

Drug Nameferroptosis inhibitors (Collaborative Medicinal Development)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutathione peroxidase 4 stimulants
TargetsGlutathione peroxidase 4
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCollaborative Medicinal Development Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCollaborative Medicinal Development Pty Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson DiseaseHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A